Related Experiment Video
Updated: Aug 7, 2025
03:40
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
399
Anticoagulation-Free Pediatric Extracorporeal Membrane Oxygenation: Single-Center Retrospective Study.
Edon J Rabinowitz1,2,3,4, Megan T Danzo3,4, Mark J Anderson5,4
1Division of Pediatric Critical Care Medicine, Washington University School of Medicine in St Louis and St Louis Children's Hospital, St Louis, MO.
Summary
Pediatric extracorporeal membrane oxygenation (ECMO) can be safely used without anticoagulation for limited periods in high-risk bleeding patients, showing low thrombosis rates. Further studies are needed to define safe anticoagulation-free time limits.
Area of Science:
- Pediatric critical care medicine
- Cardiovascular research
- Extracorporeal life support
Background:
- Anticoagulation management is critical during pediatric extracorporeal membrane oxygenation (ECMO).
- Limited data exists on the safety and efficacy of anticoagulation-free periods in pediatric ECMO.
- Understanding thrombosis and hemorrhage risks is essential for optimizing patient outcomes.
Purpose of the Study:
- To analyze hemorrhage and thrombosis data in pediatric patients undergoing anticoagulation-free ECMO.
- To identify patient and ECMO characteristics associated with thrombotic events during anticoagulation-free periods.
Main Methods:
- Retrospective cohort study of pediatric patients (0-18 years) on ECMO with an initial anticoagulation-free period of ≥6 hours.
- Utilized American Thoracic Society definitions for hemorrhage and thrombosis.
- Evaluated patient demographics, ECMO parameters, and thrombotic/hemorrhagic events.
Main Results:
- Thirty-five patients met inclusion criteria; 8% experienced thrombotic events during the anticoagulation-free period.
- Increased red blood cell (RBC) transfusion needs correlated with longer anticoagulation-free periods (p=0.03).
- Anticoagulation-free thrombotic events were associated with younger age, lower weight, lower ECMO flow rate, and longer anticoagulation-free duration.
Conclusions:
- Limited anticoagulation-free ECMO is feasible in selected high-risk pediatric bleeding patients with a low frequency of thrombosis.
- Further multicenter studies are required to establish safe anticoagulation-free time limitations based on patient and ECMO variables.
